Retaglutide is a novel GLP-1 receptor agonist currently under study for the control of obesity. This therapy works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://albertkwbq844615.dsiblogger.com/71927995/semaglutide-a-potential-solution-for-metabolic-disorders